First patients sought for groundbreaking brain tumor drug trial
Disease control
Not yet recruiting
This is the first study in people testing a new drug called MT-125, given alongside standard radiation therapy for a fast-growing type of brain cancer called glioblastoma. The main goal is to find the highest dose that is safe and tolerable for patients. Researchers will enroll u…
Phase: PHASE1 • Sponsor: Myosin Therapeutics Inc. • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC